| Unbound MEDLINE results for: | Bookmark this site | | Articles related to 18816698 [Unique ID], provided by the PubMed system | |
| |
|
| | 1 - 10 of 107 journal articles in the PubMed database | Email to a friend | | |
| Griffin TC, Weitzman S, Weinstein H, et al.
A study of rituximab and ifosfamide, carboplatin, and etoposide chemotherapy in children with recurrent/refractory B-cell (CD20+) non-Hodgkin lymphoma and mature B-cell acute lymphoblastic leukemia: A report from the Children's Oncology Group. [JOURNAL ARTICLE]
Pediatr Blood Cancer 2008 Sep 24.
Abstract | Full Citation | Find Related Articles | | Plosker GL, Figgitt DP
Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia. [Clinical Trial, Journal Article, Randomized Controlled Trial, Review]
Drugs 2003; 63(8):803-43.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Hertzberg MS, Crombie C, Benson W, et al.
Outpatient-based ifosfamide, carboplatin and etoposide (ICE) chemotherapy in transplant-eligible patients with non-Hodgkin's lymphoma and Hodgkin's disease. [Journal Article]
Ann Oncol 2003.:i11-6.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Hertzberg MS, Crombie C, Benson W, et al.
Outpatient fractionated ifosfamide, carboplatin and etoposide as salvage therapy in relapsed and refractory non-Hodgkin's and Hodgkin's lymphoma. [Journal Article]
Ann Oncol 2006 May.:iv25-iv30.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Hagemeister FB
Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue. [Journal Article, Review]
Cancer Chemother Pharmacol 2002 May.:S13-20.
Abstract | Full Citation | Find Related Articles | | Corazzelli G, Russo F, Capobianco G, et al.
Gemcitabine, ifosfamide, oxaliplatin and rituximab (R-GIFOX), a new effective cytoreductive/mobilizing salvage regimen for relapsed and refractory aggressive non-Hodgkin's lymphoma: results of a pilot study. [JOURNAL ARTICLE]
Ann Oncol 2006 May; 17(suppl_4):iv18-iv24.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Bieker R, Kessler T, Berdel WE, et al.
Rituximab in combination with platinum-containing chemotherapy in patients with relapsed or primary refractory diffuse large B-cell lymphoma. [Journal Article]
Oncol Rep 2003 Nov-Dec; 10(6):1915-7.
Abstract | Full Citation | Find Related Articles | | Abali H, Urün Y, Oksüzoğlu B, et al.
Comparison of ICE (ifosfamide-carboplatin-etoposide) versus DHAP (cytosine arabinoside-cisplatin-dexamethasone) as salvage chemotherapy in patients with relapsed or refractory lymphoma. [Journal Article]
Cancer Invest 2008 May; 26(4):401-6.
Abstract | Full Citation | Find Related Articles | | Harting R, Venugopal P, Gregory SA, et al.
Efficacy and Safety of Rituximab Combined with ESHAP Chemotherapy for the Treatment of Relapsed/Refractory Aggressive B-Cell Non-Hodgkin Lymphoma. [Journal Article]
Clin Lymphoma Myeloma 2007 May; 7(6):406-12.
Abstract | Full Citation |   |
|
| |
Advertise on this site.
|
